Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

[Botulinum toxin type A for preventive treatment of chronic migraines].

Göbel H, Heinze A.

HNO. 2012 Jun;60(6):490-5. doi: 10.1007/s00106-012-2496-z. German.

PMID:
22669437
[PubMed - indexed for MEDLINE]
2.

Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.

Jackson JL, Kuriyama A, Hayashino Y.

JAMA. 2012 Apr 25;307(16):1736-45. doi: 10.1001/jama.2012.505.

PMID:
22535858
[PubMed - indexed for MEDLINE]
3.

[Botulinum toxin type A in the prophylactic treatment of chronic migraine].

Göbel H, Heinze A.

Schmerz. 2011 Sep;25(5):563-70; quiz 571. doi: 10.1007/s00482-011-1084-6. German.

PMID:
21938606
[PubMed - indexed for MEDLINE]
4.

OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Frampton JE.

Drugs. 2012 Apr 16;72(6):825-45. doi: 10.2165/11208880-000000000-00000. Review.

PMID:
22468643
[PubMed - indexed for MEDLINE]
5.

Botox for chronic migraine.

[No authors listed]

Drug Ther Bull. 2011 Feb;49(2):22-4; quiz iii-iv. doi: 10.1136/dtb.2010.10.0008. Review.

PMID:
21304165
[PubMed - indexed for MEDLINE]
6.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.

PMID:
20647171
[PubMed - indexed for MEDLINE]
Free Article
7.

OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.

Lyseng-Williamson KA, Frampton JE.

CNS Drugs. 2012 Aug 1;26(8):717-23. doi: 10.2165/11208930-000000000-00000.

PMID:
22784019
[PubMed - indexed for MEDLINE]
8.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.

PMID:
20647170
[PubMed - indexed for MEDLINE]
Free Article
9.

Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.

Pharmacotherapy. 2009 Jul;29(7):784-91. doi: 10.1592/phco.29.7.784.

PMID:
19558252
[PubMed - indexed for MEDLINE]
10.

Licence for Botox in so-called chronic migraine.

Olesen J, Tfelt-Hansen P.

Lancet. 2010 Nov 27;376(9755):1825-6; discussion 1826. doi: 10.1016/S0140-6736(10)62165-4. No abstract available.

PMID:
21111904
[PubMed - indexed for MEDLINE]
11.

Botulinum toxin A and headache treatment.

Gady J, Ferneini EM.

Conn Med. 2013 Mar;77(3):165-6. Review.

PMID:
23589955
[PubMed - indexed for MEDLINE]
12.

A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis.

Elkind AH, O'Carroll P, Blumenfeld A, DeGryse R, Dimitrova R; BoNTA-024-026-036 Study Group.

J Pain. 2006 Oct;7(10):688-96.

PMID:
17018329
[PubMed - indexed for MEDLINE]
13.

OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.

Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.

PMID:
21883197
[PubMed - indexed for MEDLINE]
14.

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.

Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD; BOTOX CDH Study Group.

Headache. 2005 Apr;45(4):315-24.

PMID:
15836567
[PubMed - indexed for MEDLINE]
15.

Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.

Freitag FG, Diamond S, Diamond M, Urban G.

Headache. 2008 Feb;48(2):201-9. Epub 2007 Nov 28.

PMID:
18042229
[PubMed - indexed for MEDLINE]
16.

Botulinum toxin for chronic migraine.

[No authors listed]

Med Lett Drugs Ther. 2011 Jan 24;53(1356):7-8. No abstract available.

PMID:
21252842
[PubMed - indexed for MEDLINE]
17.

OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .

Torgovnick J.

Cephalalgia. 2011 Feb;31(3):377; author reply 378-9. doi: 10.1177/0333102410388529. Epub 2010 Nov 22. No abstract available.

PMID:
21098110
[PubMed - indexed for MEDLINE]
18.

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.

Silberstein S, Mathew N, Saper J, Jenkins S.

Headache. 2000 Jun;40(6):445-50.

PMID:
10849039
[PubMed - indexed for MEDLINE]
19.

Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine.

Magalhães E, Menezes C, Cardeal M, Melo A.

Clin Neurol Neurosurg. 2010 Jul;112(6):463-6. doi: 10.1016/j.clineuro.2010.02.004. Epub 2010 Apr 18.

PMID:
20399553
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin A and migraine surgery.

Guyuron B, Tucker T, Kriegler J.

Plast Reconstr Surg. 2003 Oct;112(5 Suppl):171S-173S; discussion 174S-176S. No abstract available.

PMID:
14504501
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk